Clinical Trial Update: S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial of duloxetine hydrochloride for muscle/joint pain in early-stage breast cancer patients on hormone therapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Duloxetine hydrochloride (duloxetine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Musculoskeletal Complications | Phase 3 | Status: COMPLETED | Results posted: 2018-02-28